Dr. Khalid Al-Kinani currently holds the position of Assistant Professor and Head of the Department of Pharmaceutics at the College of Pharmacy, University of Baghdad. He is also the current Chair of the Biologics and Biosimilars Registration Committee at the Iraqi Ministry of Health. Dr. Al-Kinani earned his PhD in Pharmaceutical Technology from the University of Kansas, School of Pharmacy, USA, in 2017. Prior to that, he received both his Bachelor’s and Master’s degrees in Pharmacy from the University of Baghdad, College of Pharmacy, in 2012 and 2010, respectively.
As a faculty member, Dr. Al-Kinani teaches several undergraduate and graduate courses, including Pharmaceutical Technology, Physical Pharmacy, and Advanced Drug Delivery Systems. His research primarily focuses on pharmaceutical sciences, pharmaceutical technology, and regulatory affairs. He has supervised graduate and undergraduate pharmacy students in their degree pursuits.
As the Chair of the Biologics and Biosimilars Registration Committee, Dr. Al-Kinani played a key role in introducing biosimilars by establishing Iraq’s regulatory pathway for the approval of these products through evaluation and drafting the approval and registration guidelines. Biosimilars have saved millions of dollars for the Iraqi healthcare system. Previously, he served as the Head of the Bioavailability and Bioequivalence Assessment Unit and was a member of the Technical Committee for the Pharmaceutical Industry at the Iraqi Ministry of Health.
Dr. Khalid Al-Kinani is a member of various associations, including the Parenteral Drug Association (PDA), the Iraqi Pharmacists Syndicate, and the American Association of Pharmaceutical Scientists (AAPS).
PhD in Pharmaceutics from the University of Kansas, School of Pharmacy, USA (2017). Master’s Degree in Pharmaceutics from the University of Baghdad, College of Pharmacy (2010). Bachelor’s Degree in Pharmacy from the University of Baghdad, College of Pharmacy (2012).
Assistant Professor and Head of the Department of Pharmaceutics at the College of Pharmacy, University of Baghdad. Chair of the Biologics and Biosimilars Registration Committee at the Iraqi Ministry of Health. Instructor of various courses such as Pharmaceutical Technology, Physical Pharmacy, and Advanced Drug Delivery Systems, teaching both undergraduate and graduate students. Research supervision for graduate and undergraduate pharmacy students at the University of Baghdad. Development of Iraq’s regulatory pathway for the approval of biosimilars through evaluation and drafting of guidelines for approval and registration. Leadership in cost-saving efforts for the Iraqi healthcare system by introducing biosimilars, which have saved millions of dollars. Past roles, including: Head of the Bioavailability and Bioequivalence Assessment Unit at the Iraqi Ministry of Health. Member of the Technical Committee for the Pharmaceutical Industry at the Iraqi Ministry of Health. Member of professional organizations such as the Parenteral Drug Association (PDA), the Iraqi Pharmacists Syndicate, and the American Association of Pharmaceutical Scientists (AAPS).
Certificates of Appreciation (Thirty +) – College of Pharmacy, University of Baghdad (2006-2024). Certificates of Appreciation (Two) – Syndicate of Iraqi Pharmacists (2017, 2019). Best Poster Award – Conference in California, USA (2014). Certificates of Appreciation (Two) – Iraqi Ministry of Health (2018, 2019). Certificate of Appreciation – Scientific TV show, Ur TV channel (2019).
Memberships: Parenteral Drug Association (PDA). Iraqi Pharmacists Syndicate. American Association of Pharmaceutical Scientists (AAPS).
Pharmaceutical sciences. Pharmaceutical biotechnology. Advanced drug delivery systems. Physical pharmacy. Regulatory affairs related to biologics, biosimilars, and pharmaceuticals.
Pharmaceutical Sciences Pharmaceutical Technology Regulatory Affairs
Physical Pharmacy, Lab (2006) - Pharmaceutics Industrial Pharmacy, Lab (2007-2010) - Pharmaceutics Pharmaceutical Technology (2010-2011) - Pharmaceutics Principles of Pharmacy Practice (2017-2019) - Pharmaceutics Pharmaceutical Biotechnology (2018-present) - Pharmaceutics Physical Pharmacy (2020-present) - Pharmaceutics Theory and Technology of Pharmaceutical Sciences (High Diploma Students, 2019) - Pharmaceutics Dosage Forms Design (High Diploma Students, 2020) - Pharmaceutics Advanced Biopharmaceutics (Master Students, 2020-present) - Pharmaceutics Selected Topics for PhD Students (2022-present) - Pharmaceutics Pharmaceutical Biotechnology and Biomanufacturing (2024) - Pharmaceutics
Preparation and in-vitro Evaluation of Rosuvastatin Calcium Solid Dispersion with Different Carriers as a Capsule Dosage Form (2020). Preparation and in vitro Evaluation of Allopurinol Water Dispersible Tablet (2020). Preparation and in vitro Evaluation of Amlodipine Besylate Fast Dissolving Oral Film (2020). Preparation and in vitro Evaluation of Leflunomide Nanoemulsion-Based Gel (2020). Formulation and Evaluation of Solid Dispersion-Based Pediatric Chewable Jelly of Risperidone (2022). Formulation and Characterization of Prednisolone Acetate as Ocular Bioadhesive Microemulgel (2023). Preparation and in-vitro Evaluation of Idebenone Nanoemulsion as Nasal Dosage Form (2023). Preparation and Evaluation of Propranolol as a Topical Nanoemulsion-Based Gel for Significantly Impacting Infantile Hemangioma (2024).